Souhaitez-vous accéder aux communiqués récents ?

HOUSTON, July 09, 2025 (GLOBE NEWSWIRE) -- CoRegen, Inc., a biopharmaceutical company pursuing novel treatments for patients impacted by some of the most aggressive forms of cancer, today announced...

Hingham, MA, July 08, 2025 (GLOBE NEWSWIRE) -- MAJC, co-founded by award-winning chef Matt Jennings and tech entrepreneur Andy Coughlin, today announced the official launch of the MAJC Community....

Austin, July 08, 2025 (GLOBE NEWSWIRE) -- What You’ll Learn: 2025 Consumer Shift Toward Non-Invasive Pulse Oximeters for At-Home Health Tracking In this 2025 wellness update, BloodVitals details...

Chicago, July 08, 2025 (GLOBE NEWSWIRE) -- The global bioplastics market was valued at US$ 7.35 billion in 2024 and is expected to reach US$ 19.75 billion by 2033, growing at a CAGR of 11.61% during...

SOUTH SAN FRANCISCO, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant...

NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Vaxart, Inc....

Fengate Asset Management has released its 2024 Sustainability Report, demonstrating the firm’s continued commitment to responsible investment.

PARSIPPANY, New Jersey, July 07, 2025 (GLOBE NEWSWIRE) -- Corza Medical, a leading global medical technology company, today announced the launch of its expanded Onatec Ophthalmic Suture Portfolio....

Chandler, AZ , July 02, 2025 (GLOBE NEWSWIRE) -- Local Dominator has launched a powerful product upgrade designed to simplify and supercharge local SEO for professionals and agencies: Local...

Lynozyfic is a bispecific antibody directing T cells to kill multiple myeloma cancer cells; multiple myeloma is the second most common blood cancer Approval based on pivotal Phase 1/2 LINKER-MM1...